Monthly Archives: February 2020

Flowserve Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 18, 2020 / Flowserve Corp. (NYSE:FLS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 18, 2020 at 11:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/58828

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 576736

GERN Investors:  March 23, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA / ACCESSWIRE / February 18, 2020 / The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation on behalf of investors who purchased the common stock of Geron Corporation ("Geron" or the "Company") (NASDAQ:GERN) between March 19, 2018 and September 26, 2018, inclusive (the "Class Period").

If you purchased shares of the common stock of Geron during the Class Period, you may move the Court for appointment as lead plaintiff by no later than March 23, 2020. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

Geron investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.

Geron, incorporated and headquartered in Menlo Park, California, is a biopharmaceutical company.

The complaint alleges that throughout the Class Period, Defendants misled investors regarding the results of a clinical study of a bone cancer treatment drug named imetelstat, and, as a result, Defendants' statements about Geron's business and prospects were materially false and misleading. The study, named "IMbark," was designed to evaluate whether imetelstat benefited patients diagnosed with myelofibrosis cancer. Geron developed imetelstat in partnership with Janssen Biotech, Inc. ("Janssen").

The truth about Defendants' fraudulent scheme began to emerge on March 27, 2018 when a biotechnology sector journalist published an article claiming Geron's and its CEO's prior statements to investors that imetelstat improved myelofibrosis patients' survival rate were materially false and misleading. Following this news, the price of Geron stock, which had closed at $5.98 per share on March 26, 2018, fell 29% over the next two days to close at $4.23 per share on March 28, 2018.

On September 27, 2018, Geron announced disappointing results from the IMbark study showing that patients had shown only 10% spleen volume reduction and only a 32% reduction in symptom response rate. In addition, Geron disclosed that Janssen had ended its partnership with Geron for the development of imetelstat. In response to this news, Geron's stock price plummeted from $6.23 per share to $2.31 per share the next day, a decrease of over 62%.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

The National Law Journal has recognized Lieff Cabraser as one of the nation's top plaintiffs' law firms for fourteen years. In compiling the list, the National Law Journal examines recent verdicts and settlements and looked for firms "representing the best qualities of the plaintiffs' bar and that demonstrated unusual dedication and creativity." Law360 has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm's "laser focus" and noting that our firm routinely finds itself "facing off against some of the largest and strongest defense law firms in the world." Benchmark Litigation has named Lieff Cabraser one of the "Top 10 Plaintiffs' Firms in America."

For more information about Lieff Cabraser and the firm's representation of investors, please visit https://www.lieffcabraser.com/.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact for Media Inquiries Only

Sharon M. Lee
Lieff Cabraser Heimann & Bernstein, LLP
Telephone: 1-800-541-7358

SOURCE: Lieff Cabraser Heimann & Bernstein, LLP

ReleaseID: 576567

New Jersey Mining Company Discusses “Production-based Exploration” and Participation in the Vancouver Resource Investment Conference

COEUR D'ALENE, ID / ACCESSWIRE / February 18, 2020 / New Jersey Mining Company (OTCQB:NJMC)(CSE:NJMC) ("NJMC" or the "Company") today discusses "production-based exploration" and its participation in the Vancouver Resource Investment Conference (VRIC).

This past January members of the New Jersey team (John, Rob, Monique, Ryan and Travis) exhibited at the VRIC held in Vancouver. The show was well attended, and it was evident from the mix of speakers that we are entering a cycle of higher gold prices. During the show we were requested to attend a number of "deal room" introductory meetings. This is a newer format in which the other side does the scheduling. Each meeting began with introductions and an inquiry by us as to why they wished to meet with our company. While one investment advisor admitted it was because he's from New Jersey (so we gave him a hat), the majority of folks we met were also from the U.S. and travelled to Vancouver because they have clients beginning to look for exposure to gold – and that our production profile set us apart from other juniors.

We felt that after a two-year absence the timing of the VRIC made it the correct venue to begin discussing our maturation and pivot toward "production-based exploration" – in addition to our established infrastructure, prior investment and geographic location. Our production-based strategy, by design, provides the flexibility to advance the Murray Gold Belt ourselves or with a strategic partner while maintaining the ability to walk away from terms that are not to our liking. And while we are working toward expanding production and putting drills to work, we are not interested in a less than desirable deal structure just for the sake of moving faster or being pushed to reverse engineer our message to fit an entirely different business model.

In addition to our "production-based" approach to district consolidation and exploration longevity, we shared (with attendees and "deal room" advisors) our longstanding belief that prudent portfolio management dictates having 5-10% exposure to gold and other hard assets – and as fellow investors – NJMC was purposely positioned to be a more reasonable candidate for the portion of a person's 5-10% hard-asset allocation targeted at the blue sky of discovery. We pointed to the potential for additional discoveries at the Golden Chest and within our overall land package, and that the process of successful exploration is reliant on both experience and the ability to stay in the game.

Furthermore, we had many discussions around the fact that we prove on a daily basis that our advantages are many. The increased knowledge gained through actual surface and underground gold production sets us apart from those that do not enjoy our existing year-round access, favorable Idaho jurisdiction, established Coeur d'Alene Mining District communities (workforce in place) and area of world-class and long-lived mines. There are no guarantees, however we do believe the notable absence and cost (time and money) to create the above characteristics, and associated permitting and development processes, reduces the opportunity for early stakeholders to benefit from later district consolidation, resource definition and eventual production.

As New Jersey enters a new decade, the evolution into our two-pronged strategy is the direct result of reopening and walking through the doors of history. In order to pivot toward production-based exploration it was first necessary to reach commercial production while simultaneously consolidating the Murray Gold Belt for the first time in over 100 years. Production (and the convergence of everything that goes along with it) has provided the necessary scaffolding toward our ongoing focus on investment and becoming a successful Idaho-based company.

We greatly enjoyed the "deal room" format, and for the first time in years felt that attendees better understood the difference between a speculation and an investment. And it was interesting to hear Rob discussing with visitors to our booth how we would rather mine a deposit as opposed to mining investors.

About New Jersey Mining Company

New Jersey Mining Company is headquartered in North Idaho, where it is producing gold at its Golden Chest Mine. Gold was first discovered in the Coeur d'Alene District within the Murray Gold Belt in 1879, but by 1888 mining declined as the center of activity and demand for labor shifted to the Silver Valley following the discovery of the Bunker Hill, Sunshine, Lucky Friday, and other iconic regional mines. The rebirth of the long-forgotten Murray Gold Belt has been led by NJMC, as evidenced by production from open-pit and underground operations at the Golden Chest Mine, its extensive land package and superior knowledge of the district gained from current development and production, and ongoing exploration activities.

NJMC has established a high-quality, early to advanced-stage asset base in three historic mining districts of Idaho and Montana, which includes the currently producing Golden Chest Mine. The Company's objective is to use its considerable in-house skill sets to build a portfolio of mining and milling operations, with a longer-term vision of becoming a mid-tier producer. Management is shareholder focused and owns more than 15-percent of NJMC stock.

The Company's common stock trades on the OTC-QB and the CSE Market under the symbol "NJMC."

For more information on New Jersey Mining Company go to www.newjerseymining.com or call:

Monique Hayes, Corporate Secretary/Investor Relations
Email: monique@newjerseymining.com
(208) 625-9001

Forward Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are intended to be covered by the safe harbor created by such sections. Such statements are based on good faith assumptions that New Jersey Mining Company believes are reasonable, but which are subject to a wide range of uncertainties and business risks that could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such factors include, among others, the Company's ability to continue production and revenues, the risk that the mine plan changes due to rising costs or other operational details, an increased risk associated with production activities occurring without completion of a feasibility study of mineral reserves demonstrating economic and technical viability, the risks and hazards inherent in the mining business (including risks inherent in developing mining projects, environmental hazards, industrial accidents, weather or geologically related conditions), changes in the market prices of gold and silver and the potential impact on revenues from changes in the market price of gold and cash costs, a sustained lower price environment, as well as other uncertainties and risk factors. Actual results, developments and timetables could vary significantly from the estimates presented. Readers are cautioned not to put undue reliance on forward-looking statements. NJMC disclaims any intent or obligation to update publicly such forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE: New Jersey Mining Company

ReleaseID: 576802

IEH Corporation Announces Third Quarter Fiscal 2020 Results

BROOKLYN, NY / ACCESSWIRE / February 18, 2020 / IEH Corporation (OTCQX:IEHC) today announced results for the third quarter of Fiscal Year 2020, ended December 31, 2019.

IEH Corporation reported Revenues of $8.42 million for the third quarter of fiscal year 2020, an increase of 41% as compared to Revenues of $5.98 million for the third quarter of fiscal year 2019. Operating Income was $1.45M compared to $1.12M in Q3 2019, and Net Income was $848K vs. $789K in Q3 2019. These represent increases of 29% and 7.5%, respectively.

Dave Offerman, President and CEO of IEH Corporation commented, "We're pleased to report ongoing progress and success as we approach the end of our fiscal 2020 year. Investments in personnel, equipment and capacity have all begun to bear fruit, as reflected by our substantial top-line growth. These investments in equipment and space, buttressed by our solid cash position, will continue into the next fiscal year, to support our strong backlog, and facilitate our continued growth."

About IEH Corporation

For nearly 80 years and four generations of family-run management, IEH Corporation has designed, developed, and manufactured printed circuit board (PCB) connectors, custom interconnects and contacts for high performance applications. With its signature Hyperboloid technology, IEH supplies the most durable, reliable connectors for the most demanding environments. The Company markets primarily to companies in defense, aerospace, space and industrial applications, in the United States, Canada, Europe, Southeast and Central Asia and the Mideast. The Company was founded in 1941 and is based in Brooklyn, New York.

CONTACT:

David Offerman
7184924448

SOURCE: IEH Corporation

ReleaseID: 576388

Envela Announces New DGSE Retail Store in Expansion Effort

DALLAS, TX / ACCESSWIRE / February 18, 2020 / DGSE, LLC ("DGSE"), a subsidiary of Envela Corporation (NYSE American:ELA) ("Envela" or the "Company"), announced today that it has signed an agreement for the purchase of a retail building for its next Dallas Gold & Silver Exchange store, in Lewisville, Texas.

Brick-and-mortar expansion remains a strong growth opportunity for DGSE, and the Company's invigorated financial condition makes buying rather than leasing retail stores an attractive option. The new Lewisville location is expected to open in the third quarter this year.

DGSE will continue to focus on enhancing the customer experience through convenience and access concepts honed at the flagship store. These will include an open, 3,000 square-foot showroom, cutting-edge technologies, and inviting product selection.

"We focus our efforts on meeting evolving consumer needs and exceeding their highest expectations," said Scot Mosley, President of DGSE. "We will continue to invest in bringing a best-in-class, DGSE-brand experience to customers at each of our retail locations," Mosley added.

During the next two years, DGSE anticipates providing omnichannel and immersive consumer experiences to its customers, and opening even more retail locations.

About DGSE

DGSE focuses on recommerce of luxury brands and diamonds. Its retail strategy is anchored in being an information resource for clients, bringing transparency to purchase and sale transactions, and offering value and liquidity to those seeking to buy, sell or trade jewelry, watches, diamonds or coins.

DGSE wholesales and retails jewelry, diamonds, fine watches, and precious metal bullion and rare coin products through its Charleston Gold & Diamond Exchange (www.cdgeinc.com) and Dallas Gold & Silver Exchange (www.dgse.com) operations.

DGSE strives to deliver an unrivaled customer experience. It features a broad selection of high-quality vintage and new jewelry, precious-metal bullion, rare coins, fine timepieces and diamonds, together with value pricing and a customer-friendly sales process.

DGSE has specialized in buying and selling jewelry for over 40 years, making our expert staff among the best in the business.

About Envela

Envela and its subsidiaries engage in diverse business activities within the recommerce sector. These include one of the nation's premier authenticated recommerce retailers of luxury hard assets; end-of-life asset recycling; data destruction and IT asset management; and providers of products, services and solutions to industrial and commercial companies.

Envela operates primarily via two business segments. Through DGSE, LLC, the Company will operate its Dallas Gold and Silver Exchange, Charleston Gold & Diamond Exchange, and Bullion Express brands. Under ECHG, LLC, it will operate Echo Environmental, ITAD USA and Teladvance. Envela is a Nevada corporation, headquartered in Dallas, Texas.

Additional information about Envela is available at its investor-relations site, Envela.com.

Forward-Looking Statements

This press release includes statements that may constitute "forward-looking" statements, including statements regarding potential property acquisitions, future growth, business strategies, and the future success of DGSE. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, market conditions and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release except as required by law.

Investor Relations Contact:

David Vadala
Head of Investor Relations
Envela Corporation
13022 Preston Rd Dallas, TX 75240 972.587.4030

SOURCE: Envela Corporation

ReleaseID: 576794

IGEN Networks Launches Next Generation Platform “Medallion GPS PRO” for Light-Commercial Fleets

Medallion GPS PRO available on Sprint IoT Factory Platform

MURRIETA, CA / ACCESSWIRE / February 18, 2020 / IGEN Networks Corporation (OTCQB:IGEN) (CSE:IGN), a leading innovator of cloud-based and Internet of Things (IoT) solutions for the protection and management of mobile assets, today announced its launch of its Next Generation "Medallion GPS PRO" product line targeted for Light Commercial Fleets for US markets.

"Light Commercial Fleets account for more than 13M assets in the US with more than half of these assets comprised of passenger vehicles. This segment represents the least penetrated market for fleet management solutions for reasons of perceived high costs and complexity," said Neil G Chan, CEO of IGEN Networks Corp. With our proven solutions marketed through Small-to-Medium size business channels including Sprint's IoT Factory Platform, it's been a natural transition for us to develop fleet management solutions that are more cost efficient and simpler to use for the Light Commercial Fleet owner. By incorporating our patented "Digital Telematics Signature", we can offer greater accuracy in measuring and scoring driver behavior across diverse fleets, which will be a powerful tool for assessing actuarial risk of assets and their drivers.

Medallion GPS PRO is a Commercial Fleet Management Platform designed for the Light Commercial Fleet owner, with compelling features and services at lower costs and emphasis on ease-of-use. The system is organized around both asset and driver with dispatch capabilities, automated reporting, maintenance and diagnostics reporting, driver behavior scoring, and video tutorials on demand that are built on AWS Cloud-based infrastructure.

"Medallion GPS PRO will be offered on the Sprint IoT Factory Platform as a product available for sale through Sprint's SMB and Master Agent sales channels," said Abel Sierra, VP & GM of IGEN Networks Corp. Medallion GPS PRO products will also be sold direct to municipal, state and federal governments.

The Sprint IoT Factory platform is enabled through a strategic relationship with myDevices, the Internet of Things (IoT) solutions company that "simplifies the connected world" to accelerate the development and sales of finished IoT solutions. Sprint's converged business solutions in the IoT Factory offer customers a number of advantages, including superior network spectrum holdings, powerful worldwide wireline and wireless connectivity to an incredible influx of technological innovation and resources from Sprint's parent company, SoftBank.

About IGEN Networks Corporation

IGEN Networks Corporation provides peace-of-mind to automotive consumers and their families through direct access to Internet-of-Things (IoT) cloud-based services that include Stolen Vehicle Protection, Real-time updates on asset health and Driver Behavior.

IGEN is a fully reporting company in both Canada and the United States. It is publicly traded on the OTCQB under the symbol IGEN, and listed on the CSE under the symbol IGN. For more information, please visit: www.igennetworks.net

Forward-Looking Statements

This news release may contain forward-looking statements or forward looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities law. The terms and phrases "goal", "commitment", "guidance", "expects", "would", "will", "continuing", "drive", "believes", "indicate", "look forward", "grow", "outlook", "forecasts", "intend", and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by IGEN in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors that IGEN believes are appropriate in the circumstances, including but not limited to statements regarding investment liquidity, financing options and long term goals of the Company, general economic conditions, IGEN's expectations regarding its business, customer base, strategy and prospects, and IGEN's confidence in the cash flow generation of its business. Many factors could cause IGEN's actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements, including, without limitation: risks related to competition; IGEN's reliance on key personnel; IGEN's ability to maintain and enhance its brand; and difficulties in forecasting IGEN's financial results, particularly over longer periods given the rapid technological changes, competition and short product life cycles that characterize the mobile application industry. These risk factors and others relating to IGEN that may cause actual results to differ are set forth in the under the heading "Risk Factors" in IGEN's periodic filings with the British Columbia Securities Commission and the U.S. Securities and Exchange Commission (copies of which filings may be obtained at www.sedar.com or www.sec.gov. These factors should be considered carefully, and readers should not place undue reliance on IGEN's forward-looking statements. IGEN has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

IGEN Networks Corporation
Neil Chan
1(844)332-5699

SOURCE: IGEN Networks Corp.

ReleaseID: 576398

Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals

Aytu BioScience Enters Consumer Healthcare Market with a Portfolio of Over 35 Products that Generated $24M in Revenue During Past Four Quarters

Combination Creates Specialty Rx and Consumer Pharma Company with LTM Revenue of Approximately $43M

ENGLEWOOD, CO & SAN DIEGO, CA / ACCESSWIRE / February 18, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, Inc., a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer health products, today announced that the companies have closed the acquisition of Innovus by Aytu. Through this transaction Aytu has retired all outstanding common stock of Innovus and certain Innovus warrants for consideration consisting of approximately 3.8 million shares of Aytu common stock and approximately 2 million shares of preferred stock (convertible on a 1:1 basis into common stock) and the forgiveness of $1.35 million of debt previously owed to Aytu. On a consolidated basis, Aytu will also assume $3.2 million in unsecured debt of Innovus.

Additional consideration for up to $16 million in milestone payments in the form of contingent value rights (CVRs) were issued to Innovus shareholders at the time of closing. The CVR's represent the right to be paid, in cash or Aytu common stock, up to a potential $16 million over the next five years if certain annual revenue and profitability milestones are achieved. The initial $2 million CVR payment is expected to be made, pending final independent auditor procedures, based on Innovus generating more than $24 million in revenue for the year-ended December 31, 2019.

Through this combined entity, Aytu expands into the $40 billion consumer healthcare market with a portfolio of over thirty-five consumer products competing in large therapeutic categories including diabetes, men's health, sexual wellness and respiratory health. This expanded product line broadens Aytu's portfolio beyond its $20 million prescription therapeutic portfolio to enable wider revenue distribution and consumer reach, reduced seasonality associated with Aytu's seasonal antitussive product line, and higher revenue from an expanded base of proprietary products.

Combined, Aytu and Innovus generated approximately $43 million in revenue over the preceding four quarters ended December 31, 2019. This business combination provides increased scale and enables operational synergies that can be leveraged to accelerate the combined company's growth and path to profitability.

Josh Disbrow, Chief Executive Officer of Aytu BioScience, commented, "This is an exciting day in the history of Aytu BioScience and Innovus Pharmaceuticals. As we combine our two companies, we expand our collective product portfolio and create a diversified commercial platform from which we plan to expand. With the recent expansion of our Rx portfolio and this acquisition of Innovus and its proprietary sales and marketing platform, we now have substantial revenue scale to make possible a faster path to profitability. We look forward now to getting to work to increase sales while leveraging the efficiencies we expect to gain. We're a stronger company today as a result of this business combination, and I'm proud of the work both companies' teams have done to bring this exciting transaction to a close."

Initially, the company expects to operate the commercial aspects of the Innovus consumer business separately from Aytu's prescription business, while rationalizing general and administrative expenses through the removal of Innovus' public company costs and redundant administrative and operational processes, along with the reduction in overhead, administrative and facilities costs.

The prescription product portfolio will continue to be primarily commercialized through the existing Aytu sales force, while the consumer health products will continue to be primarily commercialized via Innovus' proprietary Beyond Human® marketing platform. However, both lines of business are expected to benefit from opportunistic cross-selling such that some consumer products may be marketed in the professional market by Aytu's Rx commercial team, while the marketing of the prescription products may be bolstered through various online and direct-to-consumer marketing initiatives.

About Aytu BioScience, Inc.

Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T"). Aytu also has exclusive U.S. and Canadian rights to ZolpiMist™, the only FDA-approved oral spray prescription sleep aid. ZolpiMist is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Aytu acquired exclusive U.S. commercial rights to Tuzistra® XR, the only FDA-approved 12-hour codeine-based antitussive syrup. Tuzistra XR is a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an extended-release oral suspension. Aytu recently acquired a portfolio of six Pediatric Rx products from Cerecor. Additionally, Aytu is developing MiOXSYS®, a novel, rapid semen-analysis system with the potential to become a standard of care for the diagnosis and management of male infertility caused by oxidative stress. MiOXSYS is commercialized outside of the U.S. where it is a CE Marked, Health Canada cleared, Australian TGA approved, Mexican COFEPRAS approved product. Aytu is planning U.S.-based clinical trials in pursuit of 510k de novo medical device clearance by the FDA. Aytu's strategy is to continue building its portfolio of revenue-generating products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets. For more information visit aytubio.com.

About Innovus Pharmaceuticals, Inc.

Headquartered in San Diego, Innovus Pharmaceuticals is an emerging over the counter ("OTC") consumer goods and specialty pharmaceutical company commercializing, licensing and developing safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality. The Company is dedicated to being a leader in developing and marketing new OTC medicines and branded Abbreviated New Drug Application ("ANDA") products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription to OTC.

Contact for Investors:

James Carbonara
Hayden IR
(646) 755-7412
james@haydenir.com

SOURCE: Aytu BioScience, Inc.

ReleaseID: 576776

Garrett Hofer CT Co-Founds Inclusive Community Rugby League

NEW LONDON, CT / ACCESSWIRE / February 18, 2020 / Garrett Hofer of East Lyme, a lifelong athlete, former collegiate rugby player, and active community volunteer, has married two of his great passions by co-founding a new sports league. Garrett Hofer and co-founder Michael Meyer established the Shoreline Spartans Rugby Team in 2017. Their goal is to provide kids and teens on the Connecticut shoreline with an opportunity to learn and play rugby in a safe, supportive, inclusive, and fun environment.

"We set up a youth program that allows young girls and boys to play rugby no matter their ability," Garrett Hofer Connecticut said. "We have some children with autism, Asperger's, cognitive disabilities, and physical disabilities that all get considerable playing time."

The league also keeps costs to a minimum, making the sport accessible to low-income families. Garrett Hofer CT and Meyer both know firsthand the value athletics can have on kids and teens in school and life. Cost should not be an obstacle to reaping those benefits, the co-founders say. The Spartans host fundraisers to help offset costs for participants.

When the team had its first practice in spring 2017, there were just seven participants. Today, there are about 40, including about 20 high schoolers. Garrett Hofer and Meyers' kids play in the league and the two men are volunteer coaches.

The Spartans hold weekly practices and in 2019 hosted their first rugby tourney. The event, which included three high school teams and four youth programs from other areas, was an outstanding success. The Spartans and their fellow teams had such a great time, Garrett Hofer said, they're planning another tourney in 2020.

In addition to hosting more tourneys, Garrett Hofer and Meyer are hoping to expand the league's offerings to include summer camps, an adult league, and a women's league.

Before starting the Spartans, Garrett Hofer East Lyme played two years of Club Rugby at the University of Wyoming. Meyer, too, has a long history with rugby. Meyer was a captain at Southern Connecticut State University and played in several adult leagues, including the Connecticut Gray. Mr. Meyer was the head coach at Mitchell College rugby for eight years.

"We are very proud of the community that has formed around these young athletes. We have parents who knew nothing about rugby and now love it. We have players that were not excelling in other sports but now get to play a sport they are good at and love," Garrett Hofer said. "We teach important fundamentals at every practice, such as sportsmanship, anti-bullying, self-worth, teamwork, and the knowledge that a person can accomplish great things if they give 100 percent. We believe because of these teachings we created a great organization."

Connect with Shoreline Spartans Rugby via Facebook: https://www.facebook.com/ShorelineSpartansRugby/

CONTACT:

Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 576744

Football Coach Andy Townsend’s Tips for Student-Athletes to Improve Between Seasons

MARSHALL, TX ‌/‌ ACCESSWIRE / February 18, 2020 / The 2019-2020 football season may be drawing to a close, but for serious athletes, there's just enough time to catch a breath before next-season prep. Andy Townsend Football Coach, a lifelong athlete, has spent the past 14 years coaching, assisting, and managing football teams in Texas and Tennessee, including two national champions. Football Coach Andy Townsend is here to share a few tips for athletes to get a leg up on training before the next season begins.

First of all, football coach Andy Townsend says what all successful people know well: "practice makes perfect." Even in-between seasons, make time to practice your sport as often as possible. As author Malcolm Gladwell said in his book "Outliers: The Story of Success," based on his study of some of the world's most successful people, it takes about 10,000 hours of repeatedly practicing a task to perfect it. Football Coach Andy Townsend advises to determine what specific skills you need for your position and hone in on those before you work on others.

Secondly, when you're not on the field, put in time at the gym. Focus on building strength, endurance, and muscle mass. Fitness experts recommend to build muscle effectively, do a few sets, with a few reps each, at your max or near-max weight. For instance, you might warm up with two sets of 10 reps at a lightweight, then do five sets of five reps at a much higher weight. Ideally, by the final rep, you should be almost unable to lift the weight. Make a workout schedule and keep a record of your progress. Along the same vein, Andy Townsend Football Coach stresses the importance of eating a balanced diet high in protein and low in refined sugars.

Finally, Andy Townsend Football Coach is a big believer in football camps and even designed a camp app available for iPhone and Android to help student-athletes find a camp in their area. Some that he recommends include Football University, 1UP, VTO Sports Combine, and NFL Prep 100 Series. Camps are the ideal opportunity for serious athletes to receive tips and training from industry pros who know what college and professional league recruiters are looking for.

More on Andy Townsend Football Coach

Football Coach Andy Townsend earned his bachelor's degree from East Texas Baptist University in kinesiology and a master's degree from Greenville University in coaching. He's been on the staff of two national champions: Texas A&M Commerce (2017) and Navarro Bulldogs (2010). Part of the inaugural football class at ETBU in 2000 and a 2004 graduate, Andy Townsend Football Coach has since held multiple titles including Associate Head Coach, Director of Football Operations, Offensive Line Coach, Defensive line Coach, and Tight Ends Coach. Andy Townsend Football Coach also founded the Lone Star Pro Day held at Texas A&M Commerce, which gives players from small schools an opportunity to showcase their talents to NFL personnel. Throughout the years, Football Coach Andy Townsend has coached multiple players who have gone on to play in the NFL, including DJ Hayden, Ethan Westbrook, Dustin Vaughan, Craig Watts, Luis Perez, and Michael Onuoha.

CONTACT:

Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 576738

Sales of CMP Slurry to Grow Strong at 8% CAGR Through 2029; Aluminum Oxide Remains Preferred Material, Says Fact.MR

High demand for silicon wafers has become a key contributor towards the growth of chemical mechanical polishing (CMP) slurry manufacturers. The trend is further complemented by rising demand for application-specific variants.

DUBLIN, IRELAND / ACCESSWIRE / February 18, 2020 / The global CMP slurry market is set to thrive at a robust CAGR of 8% during 2019 – 20292, according to the projections of a new study by Fact.MR. Leading manufacturers of CMP slurry are prioritizing product innovations and capacity expansion to capture an extended base of end-use industries.

"Increasing necessity of tunable slurries with lower defectivity and high oxide removal rates will support the demand for CMP slurries," says the Fact.MR report.

Request PDF Sample of 200+ pages report on the CMP slurry market-

https://www.factmr.com/connectus/sample?flag=S&rep_id=4480

CMP Slurry Market: Key Findings

Aluminum oxide will remain preferred material, accounting for a value of US$ 1.47 Bn in 2029.
Cerium oxide CMP slurry will display a substantial growth rate; silicon wafers will remain a lucrative application segment.
Multilayer characteristics and tech advancements will generate new opportunities in the industry.
Maximum opportunities for market players abound in Asia Pacific (excluding Japan).

CMP Slurry Market: Key Driving Factors

Tech advancements in terms of fabrication and semiconductor processes will prominently drive CMP slurry market.
Advent of technology and device architecture such as 3D packaging, and 3D FinFETs continue to bolster demand for CMP slurry.
Heightening sales of semiconductor devices remain a prominent factor driving the growth of CMP slurry market.
Emergence of new materials such as tungsten and copper drive the development of application-specific CMP slurries, pushing market growth.

Key Restraint to Market Growth

Increasing stringency of regulatory framework related to environmental impact would remain the key restraint facing market.

Explore 66 figures, 84 tables in the study. Request ToC of the report at –

https://www.factmr.com/report/4480/cmp-slurry-market

Competition Landscape

The global CMP slurry market is largely consolidated. Industry leaders are focusing their efforts on commercializing product innovations in the market. Manufacturers are also working on developing products with finer particles to meet the requirements of smaller circuits in logic devices, with investments in research and development activities to keep up with the competition. The report has also profiled key players in the global CMP slurry market, including but not limited to, Hitachi Chemical Co. Ltd., Cabot Microelectronics Corporation, DuPont, DOW, BASF SE, Evonik Industries AG, and Fujifilm Holdings Corporation.

About the Report

This 200+ pages study provides in-depth forecast data on the CMP slurry market. The key categories encompassed by the report include product type (aluminum oxide, ceramic, cerium oxide, silica, and others), application (silicon wafers, optical substrates, disk-drive components, and others), and 25+ countries in key regions (North America, Latin America, Europe, APEJ, Japan, and Middle East & Africa).

Explore Fact.MR's Detailed Coverage of the Chemicals and Materials Landscape

Methyl Formate Market-The methyl formate report comprises opportunities for the manufacturers of methyl formate and analyzes the value chain analysis in detail.

Propylene Terpolymer Market– The report has been forecast based on constant currency rates. The report includes the revenue generated from sales of propylene terpolymer across all regional economies.

Hollow Fiber Membrane Market -The hollow fiber membrane market numbers have been assessed in the report based on sales and average pricing by product type.

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at Fact.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the chemicals & materials sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog – https://blog.factmr.com/
PR- https://www.factmr.com/media-release/1259/global-cmp-slurry-market

SOURCE: FactMR

ReleaseID: 576803